2
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Lung Neoplasms
23
Breast Neoplasms
11
Prostatic Neoplasms
10
Stomach Neoplasms
7
Carcinoma, Hepatocellular
6
Small Cell Lung Carcinoma
4
Melanoma
4
Lymphoma
4
Colorectal Neoplasms
4
Uterine Cervical Neoplasms
3
Rectal Neoplasms
3
Pancreatic Neoplasms
3
Neoplasms
3
Multiple Pulmonary Nodules
3
Head and Neck Neoplasms
3
Gastrointestinal Neoplasms
3
Disease
3
Colonic Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Urinary Bladder Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Smoking Cessation
2
Smoking
2
Sarcopenia
2
Recurrence
2
Ovarian Neoplasms
2
Neuroendocrine Tumors
2
Neoplasm Metastasis
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Large B-Cell, Diffuse
2
Interventions
fludarabine phosphate
29
Etoposide
26
pegaspargase
24
Peripheral Blood Stem Cell Transplantation
23
Cyclophosphamide
23
Whole-Body Irradiation
21
Mycophenolic Acid
21
Gemcitabine
19
Busulfan
19
Methotrexate
16
Dexamethasone
16
Tacrolimus
15
Cyclosporine
14
Antilymphocyte Serum
13
Radiotherapy
12
Oxaliplatin
10
Rituximab
9
Melphalan
8
Asparaginase
8
Doxorubicin
7
Bortezomib
7
spartalizumab
6
Vorinostat
6
Lenalidomide
6
Flow Cytometry
6
tislelizumab
5
Vincristine
5
Therapeutics
5
Methylprednisolone
5
Everolimus
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Lymphoma, Extranodal NK-T-Cell
×
Tomography, X-Ray Computed
×
Clear all
NCT06362148
2026-05-01
CIRCULATE
University of Aarhus
Active not recruiting
50 enrolled